[Summary] Integrating research and development, production, sales, and services
Xiamen Amoy Diagnostics Co., Ltd. was founded in 2008 by Professor Zheng Limou, a national distinguished expert, upon his return to China. The company focuses on the field of molecular diagnostics for precision oncology, committing to technological innovation that benefits the public, and striving to provide patients with compliant, high-quality diagnostic products and services, enabling them to truly benefit from precision medicine.
The company holds qualifications including National Enterprise Technology Center, Postdoctoral Research Station, NMPA Gene Testing Technology Application Demonstration Center, National High-Tech Enterprise, and Fujian Province Tumor High-Throughput Sequencing Engineering Research Center. Its GMP-standard facilities have obtained certification from the National Medical Products Administration (NMPA) and ISO13485 certification from the EU. The company owns core technologies such as ADx-ARMS®, Super-ARMS®, ddCapture®, and ADx-HANDLE®, which have been granted patents in China, the United States, the European Union, and Japan, and have won the Second Prize of the National Science and Technology Progress Award and the Silver Medal of the China Patent Award. The company's products cover major cancer types suitable for precision medicine, and many products remain without competitors. In addition to large-scale application in top-tier hospitals across China, some products have been approved for marketing in Japan and South Korea and included in local medical insurance, pioneering overseas approval of tumor companion diagnostics in China. Furthermore, the company operates Xiamen Amoy Medical Laboratory and Shanghai Xiawei Medical Laboratory, which hold medical institution practice licenses and CAP accreditation from the College of American Pathologists, specializing in third-party clinical testing services. Currently, customers from dozens of countries and regions worldwide have chosen Amoy products and services, benefiting hundreds of thousands of cancer patients annually and effectively preventing misuse and abuse of oncology drugs.
Aiming at the source of industrial innovation, the company empowers clinical trials of innovative drugs through companion diagnostics. It is a strategic partner in oncology drug development for well-known domestic and international pharmaceutical companies such as AstraZeneca, Johnson & Johnson, Amgen, Lilly, Merck, Eisai, Hengrui, and BeiGene, jointly building the future of precision oncology.
What does Xiamen Amoy Diagnostics Co., Ltd. require? Who is Amoy Diagnostics hiring? Amoy Diagnostics recruitment: 销售类占比最多占53.8%，其次是医疗卫生/美容保健类占40.9%. What education can get in at Amoy Diagnostics? 本科占比最多占38.3%，其次是大专占30.3%. High education required at Amoy Diagnostics? 硕士占22.7%，博士占0.4%. Work experience required at Amoy Diagnostics? 不限占比最多占42.4%，其次是1-3年占30.7%. Where are the job locations at Amoy Diagnostics? 上海占比最多占20.1%，其次是厦门占18.9%. Based on job postings from the past year, for reference only.
Provided by
Featuring 104 companies ，3 followers
Featuring 89 companies ，2 followers
Featuring 91 companies ，2 followers
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
